BD India Initiated Workshop aims to achieve consensus in Standardizing AML-MRD Assay by Flow Cytometry Testing bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
To achieve a consensus on a suitable panel and analysis strategy to report Acute Myeloid Leukemia - Measurable Residual Disease (AML-MRD) by flow cytometry, BD
BD India Initiated Workshop aims to achieve consensus in Standardizing AML-MRD Assay by Flow Cytometry Testing indiagazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiagazette.com Daily Mail and Mail on Sunday newspapers.
Vellore (Tamil Nadu) [India], December 9 (ANI/NewsVoir): BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company) in collaboration with The Cytometry Society of India, Christian Medical College - Vellore organized a 2-day workshop for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma
Get latest articles and stories on Business at LatestLY. BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company) in collaboration with The Cytometry Society of India, Christian Medical College - Vellore organized a 2-day workshop for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma. This knowledge-sharing workshop was attended by nearly 100 participants, from across the country, Sri Lanka, Bangladesh, Nepal, Philippines, and Korea. Eminent speakers from leading medical colleges and hospitals elaborated on the technical and analytical components of MRD assessment. Business News | BD Life Sciences - Biosciences Facilitates Knowledge-sharing Platform for Laboratory Personnel.